Tumor Epression of Major Vault Protein is an Adverse Prognostic Factor for Radiotherapy Outcome in Oropharyngeal Carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 1, 2007, Pages 133-140

  Silva, Priyamal ^a   West, Catharine M ^a   Slevin, Nick ^b   Valentine, Helen ^a   Ryder, W David J ^b   Hampson, Lynne ^e   Bibi, Rufzan ^e   Sloan, Philip ^c   Thakker, Nalin ^c   Homer, Jarrod ^b,d   Hampson, Ian ^e  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c University Dental   (United Kingdom)

^d Manchester Royal Inf Irmary   (United Kingdom)

^e ST MARY S HOSPITAL   (United Kingdom)

Author keywords

HNSCC; LRP; MVP; Radioresistance; Tongue; Tonsil

Indexed keywords

CHROMOSOMES; DRUG THERAPY; ONCOLOGY; PROTEINS; RADIOTHERAPY;

HNSCC; RADIORESISTANCE; TONGUE;

TUMORS;

LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; RIBONUCLEOPROTEIN; TUMOR PROTEIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ANEMIA; ARTICLE; BIOPSY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENDER; HAZARD ASSESSMENT; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SMOKING; UNIVARIATE ANALYSIS; ANALYSIS OF VARIANCE; GENETICS; METABOLISM; MIDDLE AGED; OROPHARYNX TUMOR; RADIATION DOSE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; RADIATION TOLERANCE; RETROSPECTIVE STUDIES; TREATMENT FAILURE; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 34547850196     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.02.025     Document Type: Article

References (35)

1. Kedersha N.L., and Rome L.H. Isolation and characterization of a novel ribonucleoprotein particle: Large structures contain a single species of small RNA. J Cell Biol 103 (1986) 699-709
2. Kickhoefer V.A., Stephen A.G., Harrington L., et al. Vaults and telomerase share a common subunit, TEP1. J Biol Chem 274 (1999) 32712-32717
3. Kickhoefer V.A., Siva A.C., Kedersha N.L., et al. The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J Cell Biol 146 (1999) 917-928
4. Kickhoefer V.A., Searles R.P., Kedersha N.L., et al. Vault ribonucleoprotein particles from rat and bullfrog contain a related small RNA that is transcribed by RNA polymerase III. J Biol Chem 268 (1993) 7868-7873
5. Kedersha N.L., Miquel M.C., Bittner D., et al. Vaults. II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes. J Cell Biol 110 (1990) 895-901
6. Scheffer G.L., Wijngaard P.L., Flens M.J., et al. The drug resistance-related protein LRP is the human major vault protein. Nat Med 1 (1995) 578-582
7. Izquierdo M.A., Scheffer G.L., Flens M.J., et al. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am J Pathol 148 (1996) 877-887
8. Schroeijers A.B., Reurs A.W., Scheffer G.L., et al. Up-regulation of drug resistance-related vaults during dendritic cell development. J Immunol 168 (2002) 1572-1578
9. Kickhoefer V.A., Rajavel K.S., Scheffer G.L., et al. Vaults are up-regulated in multidrug-resistant cancer cell lines. J Biol Chem 273 (1998) 8971-8974
10. Schroeijers A.B., Siva A.C., Scheffer G.L., et al. The Mr 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines. Cancer Res 60 (2000) 1104-1110
11. Schroeijers A.B., Scheffer G.L., Flens M.J., et al. Immunohistochemical detection of the human major vault protein LRP with two monoclonal antibodies in formalin-fixed, paraffin-embedded tissues. Am J Pathol 152 (1998) 373-378
12. Mossink M.H., van Zon A., Scheper R.J., et al. Vaults: A ribonucleoprotein particle involved in drug resistance?. Oncogene 22 (2003) 7458-7467
13. Huffman K.E., and Corey D.R. Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line. Biochemistry 44 (2005) 2253-2261
14. Chugani D.C., Rome L.H., and Kedersha N.L. Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex. J Cell Sci 106 (1993) 23-29
15. Siva A.C., Raval-Fernandes S., Stephen A.G., et al. Up-regulation of vaults may be necessary but not sufficient for multidrug resistance. Int J Cancer 92 (2001) 195-202
16. Mitchell J.B., Russo A., Cook J.A., et al. Tumor cell drug and radiation resistance: Does an interrelationship exist?. Cancer Treat Res 48 (1989) 189-203
17. Hill B.T., Whelan R.D., Hosking L.K., et al. Interactions between antitumor drugs and radiation in mammalian tumor cell lines: Differential drug responses and mechanisms of resistance following fractionated X-irradiation or continuous drug exposure in vitro. Natl Cancer Inst Monogr (1988) 177-181
18. Shimamoto Y., Sumizawa T., Haraguchi M., et al. Direct activation of the human major vault protein gene by DNA-damaging agents. Oncol Rep 15 (2006) 645-652
19. Raval-Fernandes S., Kickhoefer V.A., Kitchen C., et al. Increased susceptibility of vault poly(ADP-ribose) polymerase-deficient mice to carcinogen-induced tumorigenesis. Cancer Res 65 (2005) 8846-8852
20. Hampson L., El Hady E.S., Moore J.V., Kitchener H.C., and Hampson I.N. The HPV16 E6 and E7 proteins and the radiation resistance of cervical carcinoma. FASEB J 15 (2001) 1445-1447
21. Madhusudan S., and Middleton M.R. The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer. Cancer Treat Rev 31 (2005) 603-617
22. Gray R.J. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16 (1988) 1141-1154
23. Thomas G.R., Nadiminti H., and Regalado J. Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int J Exp Pathol 86 (2005) 347-363
24. Yu Z., Fotouhi-Ardakani N., Wu L., et al. PTEN associates with the vault particles in HeLa cells. J Biol Chem 277 (2002) 40247-40252
25. Li J., Yen C., Liaw D., et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275 (1997) 1943-1947
26. Chung J.H., Ginn-Pease M.E., and Eng C. Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) has nuclear localization signal-like sequences for nuclear import mediated by major vault protein. Cancer Res 65 (2005) 4108-4116
27. Chung J.H., and Eng C. Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis. Cancer Res 65 (2005) 8096-8100
28. Lohrer H.D. Regulation of the cell cycle following DNA damage in normal and Ataxia telangiectasia cells. Experientia 52 (1996) 316-328
29. Brugger D., Brischwein K., Liu C., et al. Induction of drug resistance and protein kinase C genes in A2780 ovarian cancer cells after incubation with antineoplastic agents at sublethal concentrations. Anticancer Res 22 (2002) 4229-4232
30. Yi C., Li S., Chen X., et al. Major vault protein, in concert with constitutively photomorphogenic 1, negatively regulates c-Jun-mediated activator protein 1 transcription in mammalian cells. Cancer Res 65 (2005) 5835-5840
31. Butel J.S. Viral carcinogenesis: Revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 21 (2000) 405-426
32. Schlecht N.F. Prognostic value of human papillomavirus in the survival of head and neck cancer patients: An overview of the evidence. Oncol Rep 14 (2005) 1239-1247
33. Hampson L., Li C., Oliver A.W., et al. The PDZ protein Tip-1 is a gain of function target of the HPV16 E6 oncoprotein. Int J Oncol 25 (2004) 1249-1256
34. Kozomara R., Jovic N., Magic Z., et al. p53 Mutations and human papillomavirus infection in oral squamous cell carcinomas: Correlation with overall survival. J Craniomaxillofac Surg 33 (2005) 342-348
35. Sisk E.A., Soltys S.G., Zhu S., et al. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. Head Neck 24 (2002) 841-849